LLY Q4 2018 Earnings Report — Eli Lilly and Company Revenue & Financial Results | Market Cap Arena

Eli Lilly and CompanyLLY

Q4 2018 Earnings

Reported February 19, 2019

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q4 2018	Q3 2018	Q4 2017	QoQ Change	YoY Change
Revenue	$6.4B	$5.3B	$6.2B	21.3%	4.5%
Op. Income	$1.6B	$1.5B	$769M	8.1%	107.9%
Gross Margin	75.2%	78.3%	73.6%	-3.0pp	1.6pp
Net Margin	17.5%	21.7%	-26.9%	-4.2pp	44.4pp
EPS (Diluted)	$1.10	$1.12	$-1.50	-1.8%	173.3%
Free Cash Flow	$825M	$1.8B	$1.3B	-54.7%	-34.0%

Revenue Flow

Item	Amount
REVENUE	$6.4B
Cost of Revenue	$1.6B
GROSS PROFIT	$4.8B
R&D Expenses	$1.5B
Selling & Marketing	$0
General & Administrative	$1.8B
SG&A Expenses	$1.8B
Other Expenses	$0
Operating Expenses	$3.2B
Cost & Expenses	$4.8B
OPERATING INCOME	$1.6B
Interest Income	$43M
Interest Expense	$78M
Other Income/Expenses	-$659M
INCOME BEFORE TAX	$939M
Income Tax Expense	-$186M
Net Income from Continuing Ops	$1.1B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.1B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.1B
D&A	$346M
EBIT	$1.0B
EBITDA	$1.4B
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$6.4B
Cost of Revenue	$1.6B
GROSS PROFIT	$4.8B
R&D Expenses	$1.5B
Selling & Marketing	$0
General & Administrative	$1.8B
SG&A Expenses	$1.8B
Other Expenses	$0
Operating Expenses	$3.2B
Cost & Expenses	$4.8B
OPERATING INCOME	$1.6B
Interest Income	$43M
Interest Expense	$78M
Other Income/Expenses	-$659M
INCOME BEFORE TAX	$939M
Income Tax Expense	-$186M
Net Income from Continuing Ops	$1.1B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.1B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.1B
D&A	$346M
EBIT	$1.0B
EBITDA	$1.4B
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$1.1B
Depreciation & Amortization	$346M
Stock-Based Compensation	$73M
Deferred Income Tax	$165M
Other Non-Cash Items	$481M
Change in Working Capital	-$741M
OPERATING CASH FLOW	$1.4B
Capital Expenditure	-$624M
Acquisitions (Net)	$0
Purchases of Investments	-$118M
Sales/Maturities of Investments	$82M
Other Investing Activities	-$228M
NET CASH FROM INVESTING	-$659M
Net Debt Issuance	$92M
Common Stock Repurchased	-$1.1B
Common Dividends Paid	-$573M
Other Financing Activities	-$59M
NET CASH FROM FINANCING	-$1.6B
FREE CASH FLOW	$825M
Net Change in Cash	-$962M

Balance Sheet

Item	Amount
Cash & Equivalents	$7.3B
Short-Term Investments	$88M
Net Receivables	$5.8B
Inventory	$3.1B
Other Current Assets	$2.2B
TOTAL CURRENT ASSETS	$20.5B
PP&E (Net)	$8.0B
Goodwill	$1.4B
Intangible Assets	$1.1B
Long-Term Investments	$2.0B
Tax Assets	$2.6B
Other Non-Current Assets	$8.3B
TOTAL NON-CURRENT ASSETS	$23.4B
TOTAL ASSETS	$43.9B
Account Payables	$1.2B
Short-Term Debt	$1.1B
Deferred Revenue	$0
Other Current Liabilities	$3.7B
TOTAL CURRENT LIABILITIES	$11.9B
Long-Term Debt	$9.2B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$1.3B
Other Non-Current Liabilities	$10.6B
TOTAL NON-CURRENT LIABILITIES	$21.1B
TOTAL LIABILITIES	$33.0B
Common Stock	$661M
Additional Paid-In Capital	$6.6B
Retained Earnings	$11.4B
Treasury Stock	-$69M
Accum. Other Comp. Income	-$8.7B
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$9.8B
Minority Interest	$1.1B
TOTAL EQUITY	$10.9B
TOTAL LIABILITIES & EQUITY	$43.9B
Total Debt	$10.3B
Net Debt	$3.0B